Co-Diagnostics, Inc. Contracts with Promega Corp for COVID-19 Test Manufacturing as Company Expands Domestic Customer Base
Read the full press release from CISION PR Newswire here. Co-Diagnostics, Inc.(Nasdaq: CODX)(the Company), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has contracted with Madison, Wisconsin-based Promega…